DAIC

DECEMBER 14, 2023

Henry Ford Health's National Cardiogenic Shock Initiative research team. Cardiogenic shock is a critical condition in which the heart is unable to pump enough blood to sustain the body’s needs, depriving vital organs of blood supply. Patients were enrolled between July 2016 and December 2020.

Cardiogenic Shock 105

Cardiogenic Shock Heart Attack Heart attacks Myocardial Infarction 105

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundVenoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly used for patients with cardiogenic shock. Although Impella or intra‐aortic balloon pump (IABP) is frequently used for left ventricular unloading (LVU) during VA‐ECMO treatment, there are limited data on comparative outcomes. versus 25.8%;P‐trend<0.001).

Cardiogenic Shock 65

Cardiogenic Shock Aortic Hospital Outcomes 65

Circulation

NOVEMBER 11, 2024

CHD admissions remained stable from 2016 to 2020. Cardiogenic shock rates were highest among SV-CHD patients, with significant fluctuations, followed by DV-CHD patients. Variations in cardiogenic shock, MCS usage, and cardiac transplants emphasize the need for adaptive clinical practices to optimize patient outcomes.

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

Journal of the American Heart Association

JANUARY 10, 2025

Using inverse probability treatment weighting, we assessed for the association between device type and clinical outcomes. The primary outcome was allcause mortality. The primary outcome was allcause mortality. We identified 2879 patients without CS who underwent PCI with either an intraaortic balloon pump or microaxial LVAD.

Cardiogenic Shock 40

Cardiogenic Shock Outcomes Stroke Strokes 40

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

In the light of increasing availability, the analyses of outcome-relevant predisposing characteristics are of growing importance. Methods We retrospectively analysed the data of 377 consecutive patients treated for OHCA using eCPR in our cardiac arrest centre from January 2016 to December 2022.

Cardiogenic Shock 64

Cardiogenic Shock Cardiac Arrest BMI Coronary Artery Disease 64

Circulation

NOVEMBER 11, 2024

As heart failure with preserved ejection fraction (HFpEF) comprises half of all heart failure cases, understanding its management and effect on outcomes is crucial. There was a non-significant increased risk of cardiogenic shock (aOR 1.14, 95% CI 0.87 - 1.5, adjusted odds ratio [aOR] 1.01, 95% CI 0.85 - 1.2,

Preserved Ejection Fraction 40

Preserved Ejection Fraction Inpatient Cardiogenic Shock Heart Failure 40

Circulation: Heart Failure

MARCH 8, 2024

Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs. A secondary analysis evaluated outcomes for severe HF hospitalizations (cardiogenic shock, cardiac arrest, and mechanical ventilation).

Heart Failure 40

Heart Failure Cardiogenic Shock Outcomes Cardiac Arrest 40